Cost-effectiveness analysis in Parkinson's disease: determining the value of interventions

Mov Disord. 2000 May;15(3):439-45. doi: 10.1002/1531-8257(200005)15:3<439::AID-MDS1004>3.0.CO;2-F.
No abstract available

Publication types

  • Review

MeSH terms

  • Clinical Trials as Topic
  • Cost-Benefit Analysis
  • Humans
  • Parkinson Disease / economics*
  • Parkinson Disease / therapy
  • Quality-Adjusted Life Years
  • Technology Assessment, Biomedical / economics